Scinovex
articleTop 10% cited

The prevalence and incidence of neurocognitive impairment in the HAART era

AIDS · 2007 · Vol. 21(14) · pp. 1915–1921
Kevin R. RobertsonMarlene SmurzynskiThomas D. ParsonsKunling WuRonald J. BoschJulia WuJustin C. McArthurAnn C. CollierScott EvansRonald J. Ellis

Abstract

The association of previous advanced immunosuppression with prevalent and sustained impairment suggests that there is a non-reversible component of neural injury that tracks with a history of disease progression. The association of sustained impairment with worse current immune status (low CD4 cell count) suggests that restoring immunocompetence increases the likelihood of neurocognitive recovery. Finally, the lack of association between incident neurocognitive impairment and virological and immunological indicators implies that neural injury continues in some patients regardless of the success of antiretroviral therapy on these laboratory measures.

HIV Research and TreatmentHIV/AIDS Research and InterventionsCytomegalovirus and herpesvirus researchNeurocognitiveMedicineImmunosuppressionIncidence (geometry)Clinical trialInternal medicineDiseaseImmunologyPsychiatryCognition

MeSH terms

AdultCognition DisordersFemaleHumansMaleMiddle AgedProspective StudiesRNA, ViralHIV InfectionsIncidencePrevalenceCD4 Lymphocyte CountAntiretroviral Therapy, Highly Active

Funding

  • ACT Government
Citations
624
FWCI
8.98
field-weighted impact
References
34
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.